(Q38152795)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24127850%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Mobilizing and evaluating anticancer T cells: pitfalls and solutions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24127850%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24127850%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Céline Robert-Tissot

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24127850%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Linh T Nguyen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24127850%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Daniel E Speiser

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24127850%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

1 reference

16 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24127850%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24127850%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24127850%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24127850%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

1325-1340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24127850%20AND%20SRC:MED&resulttype=core&format=json

Decisions about dendritic cells: past, present, and future

27 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Selection of the T cell repertoire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

How regulatory T cells work

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Regulatory T cells: mechanisms of differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

The three main stumbling blocks for anticancer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Antigens recognized by T-lymphocytes on human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Cancer/testis antigens, gametogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Immunotherapy earns its spot in the ranks of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

T cell receptor gene therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Treating cancer with genetically engineered T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Challenges in T cell receptor gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

T cell-based gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Molecular insights for optimizing T cell receptor specificity against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Fighting cancers from within: augmenting tumor immunity with cytokine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Immunology beats cancer: a blueprint for successful translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Tumor Immunotherapy Directed at PD-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Targeting PD-1/PD-L1 interactions for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Clinical Implications of CD8+ T-cell infiltration in frequent and rare cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Trial watch: Prognostic and predictive value of the immune infiltrate in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

From vaccines to memory and back

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Life and death in peripheral T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

The expansion and maintenance of antigen-selected CD8(+) T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Complete but curtailed T-cell response to very low-affinity antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Hit parade for adoptive cell transfer therapy: the best T cells for superior clinical responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Cancer immunotherapy via dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Dendritic cell-based cancer gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Dendritic cell-based vaccines for the therapy of experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

T-cell Receptor-optimized Peptide Skewing of the T-cell Repertoire Can Enhance Antigen Targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Simultaneous coexpression of memory-related and effector-related genes by individual human CD8 T cells depends on antigen specificity and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Exploiting the mutanome for tumor vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Death and anti-death: tumour resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Positive and negative regulation of T cell responses by fibroblastic reticular cells within paracortical regions of lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Cancer-associated fibroblasts and tumor growth--bystanders turning into key players

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Cancer associated fibroblasts (CAFs) in tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Adaptive immunity maintains occult cancer in an equilibrium state

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Molecular mechanisms of T cell co-stimulation and co-inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Cytometry: today's technology and tomorrow's horizons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Molecular signature of CD8+ T cell exhaustion during chronic viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Cutting edge: cell-extrinsic immune regulation by CTLA-4 expressed on conventional T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Sensitive gene expression profiling of human T cell subsets reveals parallel post-thymic differentiation for CD4+ and CD8+ lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Single cell analysis reveals similar functional competence of dominant and nondominant CD8 T-cell clonotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

MIFlowCyt: the minimum information about a Flow Cytometry Experiment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

"MIATA"-minimal information about T cell assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Identification of clinically useful cancer prognostic factors: what are we missing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.843456

10.1586/14760584.2013.843456

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24127850%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference